Note we may have some server downtime today and this weekend as we perform some upgrades. Please save a copy of any posts you make during this time in case we have any server trouble. Thank you!

Merck KGaA submits Rebif extention application in Europe

A board to discuss the Multiple Sclerosis modifying drug Rebif

Merck KGaA submits Rebif extention application in Europe

Postby MSUK » Wed Jun 29, 2011 2:55 am


Merck KGaA submitted an application to the European Medicines Agency or EMA to extend the indication of Rebif, its treatment for multiple sclerosis or MS. The company added that the requested label extension is for the use of Rebif in patients who have experienced a single demyelinating event, an early sign of the disease, and who are at high risk of converting to MS..... Read More - ... ageid/1901
User avatar
Family Elder
Posts: 2109
Joined: Wed Oct 14, 2009 3:00 pm

Return to Rebif


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service